MLYS Mineralys Therapeutics, Inc.

Ownership history in Catalys Pacific, LLC  ·  9 quarters on record

This page tracks every 13F SEC filing in which Catalys Pacific, LLC reported a position in Mineralys Therapeutics, Inc. (MLYS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
96.09% (2025 Q3)
Avg. % of fund
87.31%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 7,903,838 -1,000,000 -11.2% 92.37% $286.8M $36.29
2025 Q3 UNCHANGED 8,903,838 0% 96.09% $337.6M $37.92
2025 Q2 ADDED 8,903,838 +259,259 +3.0% 91.50% $120.5M $13.53
2025 Q1 UNCHANGED 8,644,579 0% 95.08% $141.4M $15.88
2024 Q4 UNCHANGED 8,644,579 0% 91.82% $106.4M $12.31
2024 Q3 REDUCED 8,644,579 -550,000 -6.0% 83.48% $104.7M $12.11
2024 Q2 UNCHANGED 9,194,579 0% 81.19% $107.6M $11.70
2024 Q1 UNCHANGED 9,194,579 0% 80.13% $118.7M $12.91
2023 Q4 INITIATED 9,194,579 74.13% $79.1M
% of Fund (quarterly)    MLYS price (monthly, adj. close)
← Back to Catalys Pacific, LLC Holdings